Access icon

Letter to the Editor September 1, 2004

Ziprasidone in the Acute Treatment of Borderline Personality Disorder in Psychiatric Emergency Services

Juan C. Pascual, MD; Sílvia Oller, MD; Joaquim Soler, PsyD; Judith Barrachina, PsyD; Enrique Álvarez, PhD; Víctor Pérez, PhD

J Clin Psychiatry 2004;65(9):1281-1283

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Agranulocytosis occurs in 1% to 2% of patients treated with clozapine. Thus, if neutropenia (absolute neutrophil count [ANC] of < 1500/µL) occurs during clozapine treatment, physicians generally interrupt the drug treatment and do not reintroduce it. Lithium and granulocyte colony-stimulating factor may be used to reverse clozapine-induced granulocytopenia.1